# Parathyroid Allotransplant for Treatment of Hypoparathyroidism

> **NCT06961071** · PHASE1,PHASE2 · RECRUITING · sponsor: **Peter Stock** · enrollment: 3 (estimated)

## Conditions studied

- Hypoparathyroidism
- Hypoparathyroidism Postprocedural
- Hypoparathyroidism Post-surgical

## Interventions

- **BIOLOGICAL:** Parathyroid Allotransplant

## Key facts

- **NCT ID:** NCT06961071
- **Lead sponsor:** Peter Stock
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-01-15
- **Primary completion:** 2028-01-15
- **Final completion:** 2028-01-15
- **Target enrollment:** 3 (ESTIMATED)
- **Last updated:** 2026-02-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06961071

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06961071, "Parathyroid Allotransplant for Treatment of Hypoparathyroidism". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06961071. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*